JP2023538807A - 補体因子ｃ３の阻害剤及びそれらの医学的使用 - Google Patents

補体因子ｃ３の阻害剤及びそれらの医学的使用 Download PDF

Info

Publication number
JP2023538807A
JP2023538807A JP2023502703A JP2023502703A JP2023538807A JP 2023538807 A JP2023538807 A JP 2023538807A JP 2023502703 A JP2023502703 A JP 2023502703A JP 2023502703 A JP2023502703 A JP 2023502703A JP 2023538807 A JP2023538807 A JP 2023538807A
Authority
JP
Japan
Prior art keywords
compstatin
pharmaceutically acceptable
acceptable salt
sar
peg3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023502703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023538807A5 (https=
Inventor
アンヌ ペニーレ トフテン シェルトン
ヘンリック フィッシャー ムンク
ラスマス レット
Original Assignee
セッドぺー エスぺーヴェー ３ カー／エス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セッドぺー エスぺーヴェー ３ カー／エス filed Critical セッドぺー エスぺーヴェー ３ カー／エス
Publication of JP2023538807A publication Critical patent/JP2023538807A/ja
Publication of JP2023538807A5 publication Critical patent/JP2023538807A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
JP2023502703A 2020-07-16 2021-07-15 補体因子ｃ３の阻害剤及びそれらの医学的使用 Pending JP2023538807A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20186297 2020-07-16
EP20186297.6 2020-07-16
PCT/EP2021/069798 WO2022013374A1 (en) 2020-07-16 2021-07-15 Inhibitors of complement factor c3 and their medical uses

Publications (2)

Publication Number Publication Date
JP2023538807A true JP2023538807A (ja) 2023-09-12
JP2023538807A5 JP2023538807A5 (https=) 2024-07-24

Family

ID=71661768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502703A Pending JP2023538807A (ja) 2020-07-16 2021-07-15 補体因子ｃ３の阻害剤及びそれらの医学的使用

Country Status (11)

Country Link
US (1) US20230287051A1 (https=)
EP (1) EP4182023A1 (https=)
JP (1) JP2023538807A (https=)
KR (1) KR20230039718A (https=)
CN (1) CN116209671A (https=)
AU (1) AU2021309548A1 (https=)
CA (1) CA3185730A1 (https=)
CO (1) CO2023001411A2 (https=)
IL (1) IL299870A (https=)
MX (1) MX2023000679A (https=)
WO (1) WO2022013374A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020128624A (ru) 2018-02-27 2022-03-28 Зп Спв 3 К/С Аналоги компстатина и их медицинское применение
CA3204051A1 (en) 2021-01-20 2022-07-28 Brian Lian Compositions and methods for the treatment of metabolic and liver disorders
JP7642830B2 (ja) 2021-09-15 2025-03-10 バイキング・セラピューティクス・インコーポレイテッド 代謝及び肝臓障害の処置のための組成物及び方法
CN120359233A (zh) * 2022-11-24 2025-07-22 阿麦达斯制药美国有限责任公司 用于基于载体的疗法的坎普他汀类似物
CN118812653A (zh) * 2023-04-18 2024-10-22 成都奥达生物科技有限公司 一种长效坎普他汀化合物
CN119219741A (zh) * 2023-06-29 2024-12-31 刘晓蓉 新型补体抑制剂及其制备、应用和产品

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140113874A1 (en) * 2010-09-23 2014-04-24 The Trustees Of The University Of Pennsylvania Modified Compstatin With Improved Stability And Binding Properties
JP2014529900A (ja) * 2011-08-31 2014-11-13 ハンツマン・アドヴァンスト・マテリアルズ・（スイッツランド）・ゲーエムベーハー 空心リアクトルの含浸方法、含浸空心リアクトル、および含浸システムの使用
WO2015142701A1 (en) * 2014-03-17 2015-09-24 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved potency and pharmacokinetic properties
WO2019166411A1 (en) * 2018-02-27 2019-09-06 Zealand Pharma A/S Compstatin analogues and their medical uses
JP2022545916A (ja) * 2019-08-27 2022-11-01 セトペー エスペーベー ３ コマンディト セルスカブ コンプスタチン類似体及びその医学的使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319897B1 (en) 1996-03-13 2001-11-20 John D. Lambris Peptides which inhibit complement activation
AU723268B2 (en) 1996-09-09 2000-08-24 Zealand Pharma A/S Improved solid-phase peptide synthesis and agent for use in such synthesis
WO1999013899A1 (en) 1997-09-17 1999-03-25 Trustees Of The University Of Pennsylvania Peptides and peptidomimetics for inhibiting complement activation
PT1549333E (pt) 2002-09-20 2012-01-03 Univ Pennsylvania Análogos de compstatina com actividade melhorada
EP2662089A3 (en) 2005-10-08 2014-02-19 Potentia Pharmaceuticals, Inc. Compstatin and analogs thereof for eye disorders
CN102977191B (zh) 2005-11-28 2016-08-10 宾夕法尼亚州大学理事会 有效的c3补体抑制素类似物
WO2008153963A1 (en) 2007-06-08 2008-12-18 The Trustees Of The University Of Pennsylvania Structure of compstatin-c3 complex and use for rational drug design
CA2847862C (en) 2011-09-07 2021-01-12 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved pharmacokinetic properties
US9512180B2 (en) 2012-12-19 2016-12-06 The Regents Of The University Of California Compstatin analogs

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140113874A1 (en) * 2010-09-23 2014-04-24 The Trustees Of The University Of Pennsylvania Modified Compstatin With Improved Stability And Binding Properties
JP2014529900A (ja) * 2011-08-31 2014-11-13 ハンツマン・アドヴァンスト・マテリアルズ・（スイッツランド）・ゲーエムベーハー 空心リアクトルの含浸方法、含浸空心リアクトル、および含浸システムの使用
WO2015142701A1 (en) * 2014-03-17 2015-09-24 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved potency and pharmacokinetic properties
WO2019166411A1 (en) * 2018-02-27 2019-09-06 Zealand Pharma A/S Compstatin analogues and their medical uses
JP2022545916A (ja) * 2019-08-27 2022-11-01 セトペー エスペーベー ３ コマンディト セルスカブ コンプスタチン類似体及びその医学的使用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ACS CHEM.BIOL., vol. 6, JPN6025032882, 2011, pages 753 - 760, ISSN: 0005661459 *
CHEM.SCI., vol. 7, JPN6025032883, 2016, pages 7007 - 7012, ISSN: 0005661460 *
CHINESE CHEM.LETT., vol. 29, JPN6025032884, 2018, pages 1033 - 1042, ISSN: 0005661461 *

Also Published As

Publication number Publication date
EP4182023A1 (en) 2023-05-24
MX2023000679A (es) 2023-04-18
CA3185730A1 (en) 2022-01-20
AU2021309548A1 (en) 2023-02-23
CO2023001411A2 (es) 2023-02-16
KR20230039718A (ko) 2023-03-21
IL299870A (en) 2023-03-01
WO2022013374A1 (en) 2022-01-20
US20230287051A1 (en) 2023-09-14
CN116209671A (zh) 2023-06-02

Similar Documents

Publication Publication Date Title
JP7819087B2 (ja) インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用
TWI882061B (zh) 介白素-23受體之肽抑制劑及其治療發炎性疾病之用途
JP2023538807A (ja) 補体因子ｃ３の阻害剤及びそれらの医学的使用
US12600749B2 (en) Compstatin analogues and their medical uses
JP7711044B2 (ja) コンプスタチン類似体及びその医学的使用
EP3062823B1 (en) Novel polypeptides
EA051613B1 (ru) Ингибиторы фактора с3 системы комплемента и варианты их применения в медицине
HK40092906A (zh) 补体因子c3的抑制剂及其医学用途
EA049126B1 (ru) Аналоги компстатина и пути их медицинского применения
HK40102364A (en) Compstatin analogues and their medical uses
JP2020011906A (ja) セレン含有アミノ酸を含む糖鎖−ポリペプチド複合体、および、その医薬用途
HK40102364B (en) Compstatin analogues and their medical uses
KR20250166123A (ko) 신경계 복구를 위한 단백질 티로신 포스파타제 웨지 도메인 펩티드 이량체
HK1227702B (en) Novel polypeptides
HK1227702A1 (en) Novel polypeptides

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230314

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240702

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240702

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20240913

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240913

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20240930

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250812

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260303